more general categories |
information about this item |
|
1. Human Genes |
|
|
|
1. Human Genes |
|
|
cannabinoid receptor 2 (macrophage) [HGNC:CNR2] (29) |
|
|
2. Interaction: Human Genes and Chemicals |
|
|
|
2. Interaction: Human Genes and Chemicals |
|
|
binding (2423) |
|
|
folding (77) |
|
|
C04. Neoplasms |
|
|
|
C04. Neoplasms |
|
|
|
|
|
|
|
|
|
|
|
Leukemia, Myeloid, Acute [MESH:D015470] (2176) |
|
|
|
|
|
|
|
|
Rhabdomyosarcoma [MESH:D012208] (789) |
|
|
|
|
|
Rhabdomyosarcoma [MESH:D012208] (789) |
|
|
Carcinoma [MESH:D002277] (7263) |
|
|
Breast Neoplasms [MESH:D001943] (6077) |
|
|
Liver Neoplasms [MESH:D008113] (6048) |
|
|
Pancreatic Neoplasms [MESH:D010190] (3820) |
|
|
Pancreatic Neoplasms [MESH:D010190] (3820) |
|
|
Mammary Neoplasms, Experimental [MESH:D008325] (3268) |
|
|
Mammary Neoplasms, Experimental [MESH:D008325] (3268) |
|
|
C05. Musculoskeletal Diseases |
|
|
|
C05. Musculoskeletal Diseases |
|
|
|
|
|
Muscle Spasticity [MESH:D009128] (187) |
|
|
C06. Digestive System Diseases |
|
|
|
C06. Digestive System Diseases |
|
|
|
|
|
Liver Neoplasms [MESH:D008113] (6048) |
|
|
Pancreatic Neoplasms [MESH:D010190] (3820) |
|
|
|
|
|
|
|
|
Crohn Disease [MESH:D003424] (2585) |
|
|
|
|
|
Crohn Disease [MESH:D003424] (2585) |
|
|
Hepatomegaly [MESH:D006529] (1169) |
|
|
Liver Neoplasms [MESH:D008113] (6048) |
|
|
Fatty Liver, Alcoholic [MESH:D005235] (657) |
|
|
Liver Cirrhosis, Experimental [MESH:D008106] (4589) |
|
|
Fatty Liver, Alcoholic [MESH:D005235] (657) |
|
|
Pancreatic Neoplasms [MESH:D010190] (3820) |
|
|
Pancreatitis [MESH:D010195] (1924) |
|
|
C07. Stomatognathic Diseases |
|
|
|
C07. Stomatognathic Diseases |
|
|
|
|
|
Behcet Syndrome [MESH:D001528] (1784) |
|
|
C10. Nervous System Diseases |
|
|
|
C10. Nervous System Diseases |
|
|
|
|
|
|
|
|
Multiple Sclerosis [MESH:D009103] (1716) |
|
|
Encephalomyelitis, Autoimmune, Experimental [MESH:D004681] (806) |
|
|
|
|
|
|
|
|
Huntington Disease [MESH:D006816] (540) |
|
|
Huntington Disease [MESH:D006816] (540) |
|
|
Seizures [MESH:D012640] (4502) |
|
|
Status Epilepticus [MESH:D013226] (4014) |
|
|
Epilepsy, Temporal Lobe [MESH:D004833] (1108) |
|
|
|
|
|
Encephalomyelitis, Autoimmune, Experimental [MESH:D004681] (806) |
|
|
|
|
|
|
|
|
Huntington Disease [MESH:D006816] (540) |
|
|
|
|
|
Encephalomyelitis, Autoimmune, Experimental [MESH:D004681] (806) |
|
|
Multiple Sclerosis [MESH:D009103] (1716) |
|
|
|
|
|
Huntington Disease [MESH:D006816] (540) |
|
|
Pain [MESH:D010146] (3875) |
|
|
Seizures [MESH:D012640] (4514) |
|
|
Catalepsy [MESH:D002375] (1429) |
|
|
Ataxia with vitamin E deficiency [MESH:C535393] (271) |
|
|
|
|
|
Muscle Spasticity [MESH:D009128] (187) |
|
|
|
|
|
Hyperalgesia [MESH:D006930] (3929) |
|
|
Muscular Diseases [MESH:D009135] (3538) |
|
|
Peripheral Nervous System Diseases [MESH:D010523] (6151) |
|
|
C11. Eye Diseases |
|
|
|
C11. Eye Diseases |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Behcet Syndrome [MESH:D001528] (1784) |
|
|
C12. Male Urogenital Diseases |
|
|
|
C12. Male Urogenital Diseases |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kidney Tubular Necrosis, Acute [MESH:D007683] (974) |
|
|
Kidney Failure, Chronic [MESH:D007676] (2930) |
|
|
Proteinuria [MESH:D011507] (3293) |
|
|
C13. Female Urogenital Diseases and Pregnancy Complications |
|
|
|
C13. Female Urogenital Diseases and Pregnancy Complications |
|
|
|
|
|
Endometriosis [MESH:D004715] (2461) |
|
|
|
|
|
|
|
|
|
|
|
Kidney Tubular Necrosis, Acute [MESH:D007683] (974) |
|
|
Kidney Failure, Chronic [MESH:D007676] (2930) |
|
|
Proteinuria [MESH:D011507] (3293) |
|
|
C14. Cardiovascular Diseases |
|
|
|
C14. Cardiovascular Diseases |
|
|
Not Fully Specified [NFS] (2667) |
|
|
|
|
|
|
|
|
Tachycardia [MESH:D013610] (3339) |
|
|
Myocardial Reperfusion Injury [MESH:D015428] (3500) |
|
|
Coronary Disease [MESH:D003327] (3439) |
|
|
Myocardial Reperfusion Injury [MESH:D015428] (3500) |
|
|
Hypertension [MESH:D006973] (5655) |
|
|
Hypotension [MESH:D007022] (4045) |
|
|
|
|
|
Atherosclerosis [MESH:D050197] (4188) |
|
|
Coronary Disease [MESH:D003327] (3439) |
|
|
Myocardial Reperfusion Injury [MESH:D015428] (3500) |
|
|
Myocardial Reperfusion Injury [MESH:D015428] (3500) |
|
|
Behcet Syndrome [MESH:D001528] (1784) |
|
|
C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
|
|
|
C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
|
|
|
|
|
|
|
|
Huntington Disease [MESH:D006816] (540) |
|
|
|
|
|
Hyperlipoproteinemia Type II [MESH:D006938] (707) |
|
|
Dermatitis, Atopic [MESH:D003876] (2052) |
|
|
C17. Skin and Connective Tissue Diseases |
|
|
|
C17. Skin and Connective Tissue Diseases |
|
|
|
|
|
Breast Neoplasms [MESH:D001943] (6077) |
|
|
Dermatitis, Atopic [MESH:D003876] (2052) |
|
|
Dermatitis, Atopic [MESH:D003876] (2052) |
|
|
Dermatitis, Atopic [MESH:D003876] (2052) |
|
|
Behcet Syndrome [MESH:D001528] (1784) |
|
|
C18. Nutritional and Metabolic Diseases |
|
|
|
C18. Nutritional and Metabolic Diseases |
|
|
|
|
|
Hypoglycemia [MESH:D007003] (2420) |
|
|
Diabetes Mellitus, Experimental [MESH:D003921] (4771) |
|
|
Diabetes Mellitus, Type 2 [MESH:D003924] (4219) |
|
|
|
|
|
|
|
|
Abdominal obesity metabolic syndrome [MESH:C535554] (359) |
|
|
|
|
|
|
|
|
Hypercholesterolemia [MESH:D006937] (1404) |
|
|
Hypertriglyceridemia [MESH:D015228] (808) |
|
|
Hyperlipoproteinemia Type II [MESH:D006938] (707) |
|
|
|
|
|
Hypobetalipoproteinemia, Familial, Apolipoprotein B [MESH:D052476] (131) |
|
|
Abdominal obesity metabolic syndrome [MESH:C535554] (359) |
|
|
|
|
|
Hyperlipoproteinemia Type II [MESH:D006938] (707) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ataxia with vitamin E deficiency [MESH:C535393] (271) |
|
|
Obesity [MESH:D009765] (4462) |
|
|
C19. Endocrine System Diseases |
|
|
|
C19. Endocrine System Diseases |
|
|
|
|
|
Diabetes Mellitus, Experimental [MESH:D003921] (4771) |
|
|
Diabetes Mellitus, Type 2 [MESH:D003924] (4219) |
|
|
Pancreatic Neoplasms [MESH:D010190] (3820) |
|
|
C20. Immune System Diseases |
|
|
|
C20. Immune System Diseases |
|
|
Not Fully Specified [NFS] (350) |
|
|
|
|
|
|
|
|
|
|
|
Multiple Sclerosis [MESH:D009103] (1716) |
|
|
Encephalomyelitis, Autoimmune, Experimental [MESH:D004681] (806) |
|
|
|
|
|
Dermatitis, Atopic [MESH:D003876] (2052) |
|
|
C22. Animal Diseases |
|
|
|
C22. Animal Diseases |
|
|
Mammary Neoplasms, Animal [MESH:D015674] (2735) |
|
|
C23. Pathological Conditions, Signs and Symptoms |
|
|
|
C23. Pathological Conditions, Signs and Symptoms |
|
|
|
|
|
Hepatomegaly [MESH:D006529] (1169) |
|
|
Inflammation [MESH:D007249] (5241) |
|
|
Nerve Degeneration [MESH:D009410] (4061) |
|
|
Tachycardia [MESH:D013610] (3339) |
|
|
|
|
|
Myocardial Reperfusion Injury [MESH:D015428] (3500) |
|
|
Pain [MESH:D010146] (4511) |
|
|
Hypothermia [MESH:D007035] (2075) |
|
|
|
|
|
Weight Gain [MESH:D015430] (2595) |
|
|
Obesity [MESH:D009765] (4454) |
|
|
Pain [MESH:D010146] (3869) |
|
|
Seizures [MESH:D012640] (4502) |
|
|
Catalepsy [MESH:D002375] (1429) |
|
|
Ataxia with vitamin E deficiency [MESH:C535393] (271) |
|
|
|
|
|
Muscle Spasticity [MESH:D009128] (187) |
|
|
|
|
|
Hyperalgesia [MESH:D006930] (3929) |
|
|
Proteinuria [MESH:D011507] (3293) |
|
|
C25. Chemically-Induced Disorders |
|
|
|
C25. Chemically-Induced Disorders |
|
|
Cocaine-Related Disorders [MESH:D019970] (3054) |
|
|
Marijuana Abuse [MESH:D002189] (1132) |
|
|
Substance Withdrawal Syndrome [MESH:D013375] (2956) |
|
|
|
|
|
|
|
|
Fatty Liver, Alcoholic [MESH:D005235] (657) |
|
|
D02. Organic Chemicals |
|
|
|
D02. Organic Chemicals |
|
|
|
|
|
|
|
|
Ethanolamines [MESH:D004983] (537) |
|
|
Ethanolamines [MESH:D004983] (210) |
|
|
|
|
|
Ethanolamines [MESH:D004983] (508) |
|
|
D10. Lipids |
|
|
|
D10. Lipids |
|
|
|
|
|
Endocannabinoids [MESH:D063388] (7) |
|
|
Palmitic Acids [MESH:D010169] (145) |
|
|
D27. Chemical Actions and Uses |
|
|
|
D27. Chemical Actions and Uses |
|
|
|
|
|
|
|
|
|
|
|
Cannabinoid Receptor Agonists [MESH:D063386] (6) |
|
|
|
|
|
|
|
|
|
|
|
Cannabinoid Receptor Agonists [MESH:D063386] (6) |
|
|
|
|
|
|
|
|
|
|
|
Anti-Inflammatory Agents, Non-Steroidal [MESH:D000894] (115) |
|
|
|
|
|
Antiviral Agents [MESH:D000998] (98) |
|
|
Anti-Inflammatory Agents, Non-Steroidal [MESH:D000894] (115) |
|
|
Anti-Inflammatory Agents, Non-Steroidal [MESH:D000894] (115) |
|
|
Analgesics [MESH:D000700] (62) |
|
|